From imitation to innovation: A study of China's drug R&D and relevant national policies
Author
Ding, Jingxi; Xue, Yajiong; Liang, Huigang; Shao, Rong; Chen, Yongfa
Abstract
Research & Development (R&D) plays an increasingly important role in China's pharmaceutical industry. To gain a competitive edge in the global pharmaceutical market, the current national strategy of China forcefully pushes for independent drug innovations. This article investigates the historical, legal, and institutional contexts in which China's drug R&D has evolved. Based on an analysis of the drug R&D evolution and national policies in China, it predicts the future trend of China's policies relevant to drug innovations. This paper helps to understand the impact of national policies on drug R&D in China, which can be used to inform decision-making on investments in China's pharmaceutical market or conducting technology trade and international cooperation with Chinese partners.
Date
2011
Citation:
APA:
Ding, Jingxi, & Xue, Yajiong, & Liang, Huigang, & Shao, Rong, & Chen, Yongfa. (January 2011).
From imitation to innovation: A study of China's drug R&D and relevant national policies.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/7981
MLA:
Ding, Jingxi, and Xue, Yajiong, and Liang, Huigang, and Shao, Rong, and Chen, Yongfa.
"From imitation to innovation: A study of China's drug R&D and relevant national policies". .
. (),
January 2011.
June 29, 2024.
http://hdl.handle.net/10342/7981.
Chicago:
Ding, Jingxi and Xue, Yajiong and Liang, Huigang and Shao, Rong and Chen, Yongfa,
"From imitation to innovation: A study of China's drug R&D and relevant national policies," , no.
(January 2011),
http://hdl.handle.net/10342/7981 (accessed
June 29, 2024).
AMA:
Ding, Jingxi, Xue, Yajiong, Liang, Huigang, Shao, Rong, Chen, Yongfa.
From imitation to innovation: A study of China's drug R&D and relevant national policies. .
January 2011;
():
.
http://hdl.handle.net/10342/7981. Accessed
June 29, 2024.
Collections